[1]
Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA (Epub ahead of print)
[http://dx.doi.org/10.1001/jama.2020.0757]
[http://dx.doi.org/10.1001/jama.2020.0757]
[2]
Walsh EE, Shin JH, Falsey AR. Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. J Infect Dis 2013; 208: 1634-42.
[3]
Manuel O, Estabrook M. American society of transplantation infectious diseases community of practice. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 e13511
[4]
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14: 523-34.
[5]
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) - MERS situation update, December 2019. Available from:. http://www.emro.who.int/health-topics/mers-cov/mers-outbreaks.html
[6]
Centers for Disease Control and Prevention. Coronavirus disease 2019 - Updated February 13 2020. Available from:. https://www.cdc.gov/coronavirus/2019-ncov/summary.html
[8]
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565-74.
[9]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 95(10223): 497-506.
[10]
Nishiura H, Linton NM, Akhmetzhanov AR. Initial Cluster of Novel Coronavirus (2019-nCoV) Infections in Wuhan, China is consistent with substantial human-to-human transmission. J Clin Med 2020; 9 pii: E488
[11]
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 36, 25 February 2020. Available from:. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36-covid-19.pdf?sfvrsn=2791b4e0_2
[12]
Lipsitch M, Donnelly CA, Fraser C, et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis 2015; 9 e0003846
[13]
Del Rio C, Malani PN. 2019 Novel Coronavirus-Important Information for Clinicians. JAMA 2020; 323(11): 1039-40.
[14]
Somes MP, Turner RM, Dwyer LJ, Newall AT. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis. Vaccine 2018; 36: 3199-207.
[15]
The Center for Systems Science and Engineering- Johns Hopkins University. Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE Available from:. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
[16]
Tuite AR, Fisman DN. Reporting, epidemic growth, and reproduction numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic. Ann Intern Med 2020; 172(8): 567-8.
[17]
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239-42.
[18]
Wei M, Yuan J, Liu Y, et al. novel coronavirus infection in hospitalized infants under 1 Year of Age in China. JAMA 2020; 323(13): 1313-4.
[19]
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395(10226): 809-15.
[20]
Ministero della Salute. Covid-19 - Situazione in Italia (25 Febbraio). Available from:. http://www.salute.gov.it/portale/nuovocoronavirus/dettaglio ContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5351&area=nuovoCoronavirus&menu=vuoto
Related Journals
Applied Drug Research, Clinical Trials and Regulatory Affairs
Article Metrics
22